Skip to content
Verana-logo-horizontal-5
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us
VeranaHealth_Logo
  • Clinicians
    • Member Value Tools
      • Practice Insights
      • Verana Trial Connect
      • Quality Measures Dashboards
        • MIPS Advisory Offerings
        • Manual Data Entry
    • Verana Research Network
    • Evolve Registry
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Products
    • Ophthalmology Qdata
      • Anti-VEGF Market Tracker
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
      • Other Ophthalmic Conditions
    • Oncology Qdata
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
    • Clinical Trials
      • Site Explorer
  • Solutions
    • Clinical Research
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
Contact Us

Press

Verana Health Delivers Powerful Update to RWD Bladder Cancer Database

May 21, 2026
Read More...

Verana Health Introduces Expanded Ovarian Cancer Dataset

May 19, 2026
Read More...

Verana Health Introduces World’s Largest Real-World Dataset for Prostate Cancer

April 30, 2026
Read More...

New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions

April 28, 2026
Read More...

New Study Shows Increasing Value of Real-World Data (RWD) in Clinical Trials

April 7, 2026
Read More...

Verana Health Enhances World Renowned RWD Ophthalmic Registry with Images

March 10, 2026
Read More...

Verana Health Introduces Industry First End-to-End Urologic-Oncology Datasets to Support Research

February 19, 2026
Read More...

Verana Health Named Growth and Innovation Leader in 2025 Frost Radar™ for Life Sciences Real-World Evidence Solutions

January 22, 2026
Read More...

Verana Health Enhances Site Explorer Tool to Expedite Urology Clinical Trials

January 15, 2026
Read More...

Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties

January 8, 2026
Read More...
  • 1
  • 2
  • 3
  • …
  • 25
  • Next »
VeranaHealth_Logo

San Francisco | New York | Knoxville

Search

© 2026 Verana Health. All Rights Reserved.

Privacy Policy

Cookie Policy